Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
THOUSAND OAKS, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) announced today that Roger M. Perlmutter, M.D., Ph. D., Amgen's...